Shoshi Tessler

432 total citations
11 papers, 304 citations indexed

About

Shoshi Tessler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Hematology. According to data from OpenAlex, Shoshi Tessler has authored 11 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Hematology. Recurrent topics in Shoshi Tessler's work include Neuroscience and Neuropharmacology Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epilepsy research and treatment (3 papers). Shoshi Tessler is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epilepsy research and treatment (3 papers). Shoshi Tessler collaborates with scholars based in Israel, United States and United Kingdom. Shoshi Tessler's co-authors include Richard L. M. Faull, Piers C. Emson, Bjørnar Hassel, P.C. Emson, Niels C. Danbolt, Jon Storm‐Mathisen, John Wiseman, Norman G. Bowery, Yael Lifshitz and Jeffrey J. Sable and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neuroscience.

In The Last Decade

Shoshi Tessler

10 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoshi Tessler Israel 7 232 157 92 38 31 11 304
Janniche Hammer Norway 9 256 1.1× 133 0.8× 146 1.6× 15 0.4× 46 1.5× 9 359
W. Saskia van der Hel Netherlands 11 250 1.1× 132 0.8× 159 1.7× 31 0.8× 38 1.2× 12 442
H. Ujihara Japan 9 272 1.2× 164 1.0× 73 0.8× 27 0.7× 30 1.0× 11 359
Michael Popiolek United States 12 197 0.8× 245 1.6× 69 0.8× 20 0.5× 29 0.9× 15 398
Won Je Jeon South Korea 12 169 0.7× 214 1.4× 69 0.8× 19 0.5× 23 0.7× 15 371
Marina Arribas-Blázquez Spain 8 85 0.4× 119 0.8× 80 0.9× 28 0.7× 47 1.5× 11 320
Duk-Shin Lee South Korea 11 84 0.4× 184 1.2× 42 0.5× 18 0.5× 40 1.3× 32 290
Gerald W. Saunders United States 8 179 0.8× 219 1.4× 96 1.0× 27 0.7× 43 1.4× 10 350
Clive J. Miranda United States 5 218 0.9× 109 0.7× 37 0.4× 16 0.4× 52 1.7× 34 300
Bianca R. Villa Canada 6 109 0.5× 92 0.6× 90 1.0× 15 0.4× 59 1.9× 7 286

Countries citing papers authored by Shoshi Tessler

Since Specialization
Citations

This map shows the geographic impact of Shoshi Tessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshi Tessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshi Tessler more than expected).

Fields of papers citing papers by Shoshi Tessler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshi Tessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshi Tessler. The network helps show where Shoshi Tessler may publish in the future.

Co-authorship network of co-authors of Shoshi Tessler

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshi Tessler. A scholar is included among the top collaborators of Shoshi Tessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshi Tessler. Shoshi Tessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Altman, Jessica K., James McCloskey, Vamsi Kota, et al.. (2021). Efficacy and safety of aspacytarabine (BST-236) as a single-agent, first-line therapy for patients with acute myeloid leukemia unfit for standard chemotherapy.. Journal of Clinical Oncology. 39(15_suppl). 7007–7007. 1 indexed citations
3.
Zuckerman, Tsila, Ron Ram, Luiza Akria, et al.. (2019). BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study. Blood Advances. 3(22). 3740–3749. 10 indexed citations
4.
Buddington, Randal K., Victor V. Chizhikov, Igor Y. Iskusnykh, et al.. (2018). A Phosphatidylserine Source of Docosahexanoic Acid Improves Neurodevelopment and Survival of Preterm Pigs. Nutrients. 10(5). 637–637. 23 indexed citations
5.
Tessler, Shoshi, Inbal Mishalian, Stela Gengrinovitch, et al.. (2018). BST-236, a Novel Cytarabine Prodrug, Is Safer and As Effective As Cytarabine in In Vivo Leukemia Models. Blood. 132(Supplement 1). 1451–1451. 3 indexed citations
6.
Rabinovich‐Guilatt, Laura, et al.. (2015). Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects. British Journal of Clinical Pharmacology. 80(3). 436–445. 8 indexed citations
7.
8.
Hassel, Bjørnar, Shoshi Tessler, Richard L. M. Faull, & Piers C. Emson. (2007). Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease. Neurochemical Research. 33(2). 232–237. 105 indexed citations
9.
Wiseman, John, et al.. (2001). Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. Journal of Neurochemistry. 79(3). 564–575. 38 indexed citations
10.
Tessler, Shoshi, et al.. (2000). Glial glutamate transporter mRNAs in the genetically absence epilepsy rat from Strasbourg. Molecular Brain Research. 75(1). 96–104. 17 indexed citations
11.
Tessler, Shoshi, Niels C. Danbolt, Richard L. M. Faull, Jon Storm‐Mathisen, & P.C. Emson. (1999). Expression of the glutamate transporters in human temporal lobe epilepsy. Neuroscience. 88(4). 1083–1091. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026